Brown, Q. L. et al. Trends in marijuana use among pregnant and nonpregnant reproductive-aged women, 2002–2014. JAMA 317, 207–209 (2017).
National Academies of Sciences, Engineering & Medicine. The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research (National Academies of Sciences, 2017).
Martin, C. E., Longinaker, N., Mark, K., Chisolm, M. S. & Terplan, M. Recent trends in treatment admissions for marijuana use during pregnancy. J. Addict. Med. 9, 99–104. https://doi.org/10.1097/adm.0000000000000095 (2015).
Finer, L. B. & Zolna, M. R. Declines in unintended pregnancy in the United States, 2008–2011. N. Engl. J. Med. 374, 843–852. https://doi.org/10.1056/NEJMsa1506575 (2016).
Braillon, A. & Bewley, S. Committee opinion no. 722: Marijuana use during pregnancy and lactation. Obstet. Gynecol. 131, 164 (2018).
Ryan, S. A. et al. Marijuana use during pregnancy and breastfeeding: Implications for neonatal and childhood outcomes. Pediatrics 142, 3 (2018).
Beatty, J. R., Svikis, D. S. & Ondersma, S. J. Prevalence and perceived financial costs of marijuana versus tobacco use among urban low-income pregnant women. J. Addict. Res. Ther. 3, 1000135 (2012).
Volkow, N. D., Compton, W. M. & Wargo, E. M. The risks of marijuana use during pregnancy. JAMA 317, 129–130 (2017).
Passey, M. E., Sanson-Fisher, R. W., D’Este, C. A. & Stirling, J. M. Tobacco, alcohol and cannabis use during pregnancy: Clustering of risks. Drug Alcohol Depend. 134, 44–50 (2014).
Metz, T. D. & Stickrath, E. H. Marijuana use in pregnancy and lactation: A review of the evidence. Am. J. Obstet. Gynecol. 213, 761–778 (2015).
Correa, F., Wolfson, M. L., Valchi, P., Aisemberg, J. & Franchi, A. M. Endocannabinoid system and pregnancy. Reproduction 152, R191–R200. https://doi.org/10.1530/rep-16-0167 (2016).
Fride, E. et al. The endocannabinoid system during development: Emphasis on perinatal events and delayed effects. Vitam. Horm. 81, 139–158. https://doi.org/10.1016/s0083-6729(09)81006-6 (2009).
Hurd, Y. et al. Marijuana impairs growth in mid-gestation fetuses. Neurotoxicol. Teratol. 27, 221–229 (2005).
Fergusson, D. M., Horwood, L. J., Northstone, K. & Team, A. S. Maternal use of cannabis and pregnancy outcome. BJOG Int. J. Obstet. Gynaecol. 109, 21–27 (2002).
El Marroun, H. et al. Intrauterine cannabis exposure affects fetal growth trajectories: The generation R study. J. Am. Acad. Child Adolesc. Psychiatry 48, 1173–1181 (2009).
Lo, J. O., Hedges, J. C. & Girardi, G. Impact of cannabinoids on pregnancy, reproductive health and offspring outcomes. Am. J. Obstet. Gynecol. (2022).
Varner, M. W. et al. Association between stillbirth and illicit drug use and smoking during pregnancy. Obstet. Gynecol. 123, 113 (2014).
Gunn, J. et al. Prenatal exposure to cannabis and maternal and child health outcomes: a systematic review and meta-analysis. BMJ Open 6, e009986 (2016).
Conner, S. N. et al. Maternal marijuana use and adverse neonatal outcomes. Obstet. Gynecol. 128, 713–723 (2016).
Fergusson, D., Horwood, L. & Northstone, K. Avon longitudinal study of pregnancy and childhood. Maternal use of cannabis and pregnancy outcome. BJOG 109, 21–27 (2002).
Corsi, D. J. et al. Maternal cannabis use in pregnancy and child neurodevelopmental outcomes. Nat. Med. 26, 1536–1540 (2020).
Natale, B. V. et al. Δ9-tetrahydrocannabinol exposure during rat pregnancy leads to symmetrical fetal growth restriction and labyrinth-specific vascular defects in the placenta. Sci. Rep. 10, 544. https://doi.org/10.1038/s41598-019-57318-6 (2020).
Rompala, G., Nomura, Y. & Hurd, Y. L. Maternal cannabis use is associated with suppression of immune gene networks in placenta and increased anxiety phenotypes in offspring. Proc. Natl. Acad. Sci. U S A https://doi.org/10.1073/pnas.2106115118 (2021).
Ryan, K. S. et al. The effects of delta-9-tetrahydrocannabinol exposure on female menstrual cyclicity and reproductive health in rhesus macaques. FS Sci. 2, 287–294. https://doi.org/10.1016/j.xfss.2021.05.001 (2021).
Hedges, J. C. et al. Chronic exposure to delta-9-tetrahydrocannabinol impacts testicular volume and male reproductive health in rhesus macaques. Fertil. Steril. 117, 698–707. https://doi.org/10.1016/j.fertnstert.2021.12.028 (2022).
Steigerwald, S. et al. Smoking, vaping, and use of edibles and other forms of marijuana among US adults. Ann. Intern. Med. 169, 890–892 (2018).
Young-Wolff, K. C. et al. Modes of cannabis administration in the year prior to conception among patients in Northern California. Addict. Behav. Rep. 15, 100416. https://doi.org/10.1016/j.abrep.2022.100416 (2022).
Dickson, B. et al. Recommendations from cannabis dispensaries about first-trimester cannabis use. Obstet. Gynecol. 131, 1031 (2018).
Wolf, D. P., Thomson, J. A., Zelinski-Wooten, M. B. & Stouffer, R. L. In vitro fertilization-embryo transfer in nonhuman primates: The technique and its applications. Mol. Reprod. Dev. 27, 261–280. https://doi.org/10.1002/mrd.1080270313 (1990).
Sibal, L. R. & Samson, K. J. Nonhuman primates: A critical role in current disease research. Ilar J. 42, 74–84. https://doi.org/10.1093/ilar.42.2.74 (2001).
Grant, K. S., Petroff, R., Isoherranen, N., Stella, N. & Burbacher, T. M. Cannabis use during pregnancy: Pharmacokinetics and effects on child development. Pharmacol. Ther. 182, 133–151. https://doi.org/10.1016/j.pharmthera.2017.08.014 (2018).
Frias, A. E. et al. Using dynamic contrast-enhanced MRI to quantitatively characterize maternal vascular organization in the primate placenta. Magn. Reason. Med. 73, 1570–1578. https://doi.org/10.1002/mrm.25264 (2015).
Lo, J. O. et al. First trimester alcohol exposure alters placental perfusion and fetal oxygen availability affecting fetal growth and development in a non-human primate model. Am. J. Obstet. Gynecol. 216, 302.e301-302.e308. https://doi.org/10.1016/j.ajog.2017.01.016 (2017).
Lo, J. O. et al. Effects of early daily alcohol exposure on placental function and fetal growth in a rhesus macaque model. Am. J. Obstet. Gynecol. 226, 130.e131-130.e111. https://doi.org/10.1016/j.ajog.2021.07.028 (2022).
Schabel, M. C. et al. Functional imaging of the nonhuman primate placenta with endogenous blood oxygen level-dependent contrast. Magn. Reson. Med. 76, 1551–1562 (2016).
Lo, J. O. et al. Novel detection of placental insufficiency by magnetic resonance imaging in the nonhuman primate. Reprod. Sci. 25, 64–73 (2018).
Frias, A. E. et al. Using dynamic contrast-enhanced MRI to quantitatively characterize maternal vascular organization in the primate placenta. Magn. Reson. Med. 73, 1570–1578 (2015).
Kilkenny, C., Browne, W. J., Cuthill, I. C., Emerson, M. & Altman, D. G. Improving bioscience research reporting: the ARRIVE guidelines for reporting animal research. PLoS Biol. 8, e1000412. https://doi.org/10.1371/journal.pbio.1000412 (2010).
Cannabis Clinicians Colorado. Medical Marijuana New Patient Success Guide. http://coscc.org/wp-content/uploads/2016/07/CCC-General-CannabisAsMedicine-2017DRAFT.pdf.
Konje, J. C., Kaufmann, P., Bell, S. C. & Taylor, D. J. A longitudinal study of quantitative uterine blood flow with the use of color power angiography in appropriate for gestational age pregnancies. Am. J. Obstet. Gynecol. 185, 608–613. https://doi.org/10.1067/mob.2001.117187 (2001).
Acharya, G. et al. Experimental validation of uterine artery volume blood flow measurement by Doppler ultrasonography in pregnant sheep. Ultrasound Obstet. Gynecol. 29, 401–406. https://doi.org/10.1002/uog.3977 (2007).
Acharya, G., Wilsgaard, T., Berntsen, G. K., Maltau, J. M. & Kiserud, T. Doppler-derived umbilical artery absolute velocities and their relationship to fetoplacental volume blood flow: A longitudinal study. Ultrasound Obstet. Gynecol. 25, 444–453. https://doi.org/10.1002/uog.1880 (2005).
Frias, A. E. et al. Maternal high-fat diet disturbs uteroplacental hemodynamics and increases the frequency of stillbirth in a nonhuman primate model of excess nutrition. Endocrinology 152, 2456–2464. https://doi.org/10.1210/en.2010-1332 (2011).
Roberts, V. H. et al. Quantitative assessment of placental perfusion by contrast-enhanced ultrasound in macaques and human subjects. Am. J. Obstet. Gynecol. 214(369), e361-368. https://doi.org/10.1016/j.ajog.2016.01.001 (2016).
Roberts, V. H. J. et al. Adverse placental perfusion and pregnancy outcomes in a new nonhuman primate model of gestational protein restriction. Reprod. Sci. 25, 110–119. https://doi.org/10.1177/1933719117704907 (2018).
Schabel, M. C. & Morrell, G. R. Uncertainty in T(1) mapping using the variable flip angle method with two flip angles. Phys. Med. Biol. 54, 1–8. https://doi.org/10.1088/0031-9155/54/1/n01 (2009).
Khong, T. Y. et al. Sampling and definitions of placental lesions: Amsterdam Placental Workshop Group consensus statement. Arch. Pathol. Lab Med. 140, 698–713. https://doi.org/10.5858/arpa.2015-0225-CC (2016).
Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: An R package for comparing biological themes among gene clusters. Omics 16, 284–287. https://doi.org/10.1089/omi.2011.0118 (2012).
Kanehisa, M. Toward understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947–1951. https://doi.org/10.1002/pro.3715 (2019).
Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30. https://doi.org/10.1093/nar/28.1.27 (2000).
Kanehisa, M., Furumichi, M., Sato, Y., Ishiguro-Watanabe, M. & Tanabe, M. KEGG: Integrating viruses and cellular organisms. Nucleic Acids Res. 49, D545–D551. https://doi.org/10.1093/nar/gkaa970 (2021).
Ohlsson, A. et al. Plasma delta-9 tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smoking. Clin. Pharmacol. Ther. 28, 409–416. https://doi.org/10.1038/clpt.1980.181 (1980).
Karschner, E. L., Darwin, W. D., Goodwin, R. S., Wright, S. & Huestis, M. A. Plasma cannabinoid pharmacokinetics following controlled oral delta9-tetrahydrocannabinol and oromucosal cannabis extract administration. Clin. Chem. 57, 66–75. https://doi.org/10.1373/clinchem.2010.152439 (2011).
Hirsch, A. J. et al. Zika virus infection in pregnant rhesus macaques causes placental dysfunction and immunopathology. Nat. Commun. 9, 263. https://doi.org/10.1038/s41467-017-02499-9 (2018).
Roberts, V. H. et al. Quantitative assessment of placental perfusion by contrast-enhanced ultrasound in macaques and human subjects. Am. J. Obstet. Gynecol. 214, 369.e361-369.e368 (2016).
Benevenuto, S. G. et al. Recreational use of marijuana during pregnancy and negative gestational and fetal outcomes: An experimental study in mice. Toxicology 376, 94–101. https://doi.org/10.1016/j.tox.2016.05.020 (2017).
Carter, R. C. et al. Alcohol, methamphetamine, and marijuana exposure have distinct effects on the human placenta. Alcohol Clin. Exp. Res. 40, 753–764. https://doi.org/10.1111/acer.13022 (2016).
Chang, X. et al. Suppression of STAT3 signaling by Δ9-tetrahydrocannabinol (THC) induces trophoblast dysfunction. Cell Physiol. Biochem. 42, 537–550. https://doi.org/10.1159/000477603 (2017).
Asch, R. & Smith, C. Effects of delta 9-THC, the principal psychoactive component of marijuana, during pregnancy in the rhesus monkey. J. Reprod. Med. 31, 1071–1081 (1986).
Bailey, J., Cunny, H., Paule, M. & Slikker, W. Jr. Fetal disposition of delta 9-tetrahydrocannabinol (THC) during late pregnancy in the rhesus monkey. Toxicol. Appl. Pharmacol. 90, 315–321 (1987).
Marchand, G. et al. Birth outcomes of neonates exposed to marijuana in utero: A systematic review and meta-analysis. JAMA Netw. Open 5, 2145653–2145653. https://doi.org/10.1001/jamanetworkopen.2021.45653 (2022).
Taneja, A., Arora, K., Chopra, I. & Naik, S. S. Pregnancy outcomes in isolated oligohydramnios during second trimester: A case series. J. Clin. Diagn. Res. 11, Qr01–Qr02. https://doi.org/10.7860/jcdr/2017/27722.10502 (2017).
Figueroa, L. et al. Oligohydramnios: A prospective study of fetal, neonatal and maternal outcomes in low-middle income countries. Reprod. Health 17, 19. https://doi.org/10.1186/s12978-020-0854-y (2020).
Lee, K., Laviolette, S. R. & Hardy, D. B. Exposure to Δ9-tetrahydrocannabinol during rat pregnancy leads to impaired cardiac dysfunction in postnatal life. Pediatr. Res. 90, 532–539. https://doi.org/10.1038/s41390-021-01511-9 (2021).
Hougaard, K. S. & Hansen, A. M. Enhancement of developmental toxicity effects of chemicals by gestational stress. A review. Neurotoxicol Teratol. 29(4), 425–445 (2007).
Edlow, A. G., Guedj, F., Sverdlov, D., Pennings, J. L. A. & Bianchi, D. W. Significant effects of maternal diet during pregnancy on the murine fetal brain transcriptome and offspring behavior. Front. Neurosci. 13, 1335. https://doi.org/10.3389/fnins.2019.01335 (2019).
Shook, L. L., Kislal, S. & Edlow, A. G. Fetal brain and placental programming in maternal obesity: A review of human and animal model studies. Prenat. Diagn. 40, 1126–1137. https://doi.org/10.1002/pd.5724 (2020).
Kawashima, A. et al. Effects of maternal smoking on the placental expression of genes related to angiogenesis and apoptosis during the first trimester. PLoS ONE 9, e106140. https://doi.org/10.1371/journal.pone.0106140 (2014).
Radhakrishna, U. et al. Maternal opioid use disorder: Placental transcriptome analysis for neonatal opioid withdrawal syndrome. Genomics 113, 3610–3617 (2021).
Winterbottom, E. F. et al. Transcriptome-wide analysis of changes in the fetal placenta associated with prenatal arsenic exposure in the New Hampshire Birth Cohort Study. Environ. Health 18, 100. https://doi.org/10.1186/s12940-019-0535-x (2019).
Fuchs Weizman, N. et al. Cannabis alters epigenetic integrity and endocannabinoid signalling in the human follicular niche. Human Reprod. 36, 1922–1931. https://doi.org/10.1093/humrep/deab104 (2021).
Roncero, C. et al. Cannabis use during pregnancy and its relationship with fetal developmental outcomes and psychiatric disorders. A systematic review. Reprod. Health 17, 25. https://doi.org/10.1186/s12978-020-0880-9 (2020).